GKB Ophthalmics Ltd (GKB) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 533212 | NSE: GKB | Medical Equipment/Supplies/Accessories | Small Cap

GKB Ophthalmics Share Price

47.22 -1.54 -3.16%
as on 05-Dec'25 14:17

GKB Ophthalmics Ltd (GKB) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 533212 | NSE: GKB | Medical Equipment/Supplies/Accessories | Small Cap

DeciZen - make an informed investing decision on GKB Ophthalmics

Based on:

M-Cap below 100cr DeciZen not available

GKB Ophthalmics stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
24.6 Cr.
52-wk low:
47.3
52-wk high:
112.5

Is GKB Ophthalmics Ltd an attractive stock to invest in?

1. Is GKB Ophthalmics Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that GKB Ophthalmics Ltd is a below average quality company.

2. Is GKB Ophthalmics Ltd undervalued or overvalued?

The key valuation ratios of GKB Ophthalmics Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is GKB Ophthalmics Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of GKB Ophthalmics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of GKB Ophthalmics:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
GKB Ophthalmics Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 64%6.5%-4.1%-4.6%-6.3%-2.1%-2.2%-3.8%-4.8%-11.7%-
Value Creation
Index
3.6-0.5-1.3-1.3-1.5-1.2-1.2-1.3-1.4-1.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 31.238.336.930.525.621.327.127.731.232.831
Sales YoY Gr.-22.9%-3.7%-17.5%-16.1%-16.5%26.8%2.5%12.4%5%-
Adj EPS -3-3.4-6.4-8.1-8.5-2.9-4.7-5.9-7-12.1-10.5
YoY Gr.-NANANANANANANANANA-
BVPS (₹) 69.771.264.968.569.96560.354.647.635.129.6
Adj Net
Profit
-1.2-1.4-2.7-3.8-4.3-1.5-2.4-3-3.5-6.1-5
Cash Flow from Ops. -11.9-4.2-3.75.36.12.12.3-1.11.4-5-
Debt/CF from Ops. -0.6-1.7-2.71.91.65.75-9.88.1-3.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 0.6%5.1%6.6%5%
Adj EPS NANANANA
BVPS-7.4%-12.9%-16.6%-26.3%
Share Price -3.4% -0.7% -22.8% -53.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-5.6-4.9-9.4-12.2-12.3-4.3-7.4-10.3-13.6-29.4-32.6
Op. Profit
Mgn %
-7.8-1.1-2.7-3.3-2.9-1.3-1.5-4-4.1-10.6-11.3
Net Profit
Mgn %
-4-3.7-7.2-12.3-16.8-6.9-8.7-10.8-11.2-18.7-17.3
Debt to
Equity
0.30.20.40.30.30.40.40.40.510.1
Working Cap
Days
29723627532835538328725823023494
Cash Conv.
Cycle
16014818219012814490786472-63

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years 6.58%

Debt to equity has increased versus last 3 years average to 1.02

Sales growth is not so good in last 4 quarters at -0.18%

Latest Financials - GKB Ophthalmics Ltd.

Standalone Consolidated
TTM EPS (₹) -10.5 -9.9
TTM Sales (₹ Cr.) 30.8 119
BVPS (₹.) 29.6 104.3
Reserves (₹ Cr.) 10 48
P/BV 1.65 0.47
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 47.26 / 112.45
All Time Low / High (₹) 12.25 / 209.20
Market Cap (₹ Cr.) 24.6
Equity (₹ Cr.) 5
Face Value (₹) 10
Industry PE 53.3

Management X-Ray of GKB Ophthalmics:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of GKB Ophthalmics - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of GKB Ophthalmics

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales31.1738.3236.9230.4725.5621.3427.0527.7331.1832.75
Operating Expenses 34.6538.7737.9031.5226.2921.9227.4928.8332.4536.23
Manufacturing Costs7.589.308.076.165.514.805.126.185.235.19
Material Costs17.9420.7220.381612.869.9213.7513.6716.7218.46
Employee Cost 6.227.077.427.566.215.816.927.459.2210.88
Other Costs 2.921.672.041.801.711.391.701.521.291.69
Operating Profit -3.48-0.45-0.99-1.05-0.73-0.57-0.45-1.10-1.27-3.48
Operating Profit Margin (%) -11.2%-1.2%-2.7%-3.5%-2.9%-2.7%-1.7%-4.0%-4.1%-10.6%
Other Income 2.311.471.052.621.383.341.962.092.081.97
Interest 1.611.261.231.391.351.341.341.501.591.89
Depreciation 1.421.341.583.433.472.992.492.542.592.64
Exceptional Items 21.822.70000-0.720000
Profit Before Tax 17.611.12-2.74-3.25-4.17-2.29-2.31-3.04-3.38-6.04
Tax 3.950.36-0.17-0.480-0.180-0.160.040.07
Profit After Tax 13.660.76-2.58-2.78-4.17-2.11-2.31-2.88-3.42-6.11
PAT Margin (%) 43.8%2.0%-7.0%-9.1%-16.3%-9.9%-8.5%-10.4%-11.0%-18.7%
Adjusted EPS (₹)32.91.8-6.2-6.0-8.3-4.2-4.6-5.7-6.8-12.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 28.9629.5926.9431.7735.2532.7730.4027.5223.9917.67
Share Capital 4.154.154.154.645.045.045.045.045.045.04
Reserves 24.8025.4422.7827.1330.2127.7325.3622.4818.9512.63
Minority Interest0000000000
Debt7.157.129.8810.049.9911.3211.2410.8210.6316.73
Long Term Debt0.130.070.020011.621.170.647.25
Short Term Debt7.027.059.8610.049.9910.329.629.659.999.48
Trade Payables5.886.064.777.517.856.825.985.217.236.98
Others Liabilities 5.557.983.839.597.339.6910.019.3410.2811.84
Total Liabilities 47.5450.7445.4258.9060.4260.6057.6352.8952.1353.22

Fixed Assets

Gross Block28.3233.0134.7645.2549.2242.3543.1741.5842.6643.42
Accumulated Depreciation15.8316.5717.7920.9624.3920.0721.9024.3026.7628.98
Net Fixed Assets 12.4916.4316.9824.2924.8322.2821.2717.2815.8914.44
CWIP 0.570.570.24001.233.293.823.783.78
Investments 10.453.770.660.323.2112.2211.9011.9011.9011.90
Inventories14.0216.0714.846.794.706.985.346.064.696.08
Trade Receivables7.917.3510.4410.8110.377.4464.886.867.49
Cash Equivalents 0.720.750.396.6110.362.101.430.410.700.89
Others Assets 1.385.801.8810.086.968.358.408.538.318.64
Total Assets 47.5450.7445.4258.9060.4260.6057.6352.8952.1353.22

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -11.90-4.20-3.715.316.132.112.33-1.141.36-5.04
PBT 17.611.12-2.74-3.25-4.17-2.29-2.31-3.04-3.38-6.04
Adjustment -19.08-0.652.803.304.142.132.252.342.232.79
Changes in Working Capital -3.46-3.37-3.655.36.182.272.4-0.412.52-1.76
Tax Paid -6.97-1.30-0.12-0.03-0.01-0-0.01-0.04-0.01-0.03
Cash Flow From Investing Activity 14.745.502.28-8.63-5.68-11.52-0.832.400.37-0.16
Capex -1.93-4.88-1.56-9.66-3.66-2.81-3.681.39-1.20-1.39
Net Investments 15.869.383.110.35-0.02-0.7910.24-0.29-0.30
Others 0.8110.730.67-2-7.921.840.771.861.53
Cash Flow From Financing Activity -2.81-1.291.419.213.310.61-1.50-2.03-1.745.12
Net Proceeds from Shares 0007.554.6500000
Net Proceeds from Borrowing -1.32-0.07-0.07-0.050.031.610.48-0.56-0.487.52
Interest Paid -1.42-1.26-1.23-1.37-1.33-1.32-1.28-1.49-1.60-1.89
Dividend Paid 0000000-000
Others -0.080.032.713.08-0.040.33-0.700.030.34-0.51
Net Cash Flow 0.02-0-0.025.883.76-8.80-0-0.78-0-0.07

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)61.742.6-9.11-9.47-12.45-6.2-7.31-9.95-13.27-29.32
ROCE (%)63.976.51-4.11-4.56-6.27-2.11-2.24-3.81-4.83-11.72
Asset Turnover Ratio0.690.830.780.580.430.350.460.50.590.62
PAT to CFO Conversion(x)-0.87-5.53N/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days124688712715115291726980
Inventory Days1621351511308210083756360
Payable Days22010597140218270170149136140

GKB Ophthalmics Ltd Stock News

GKB Ophthalmics Ltd FAQs

The current trading price of GKB Ophthalmics on 05-Dec-2025 14:17 is ₹47.22.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of GKB Ophthalmics stood at ₹24.58.
The latest P/E ratio of GKB Ophthalmics as of 04-Dec-2025 is 0.00.
The latest P/B ratio of GKB Ophthalmics as of 04-Dec-2025 is 1.65.
The 52-week high of GKB Ophthalmics is ₹112.5 and the 52-week low is ₹47.26.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of GKB Ophthalmics is ₹30.75 ( Cr.) .

About GKB Ophthalmics Ltd

GKB Ophthalmics Limited is a public limited company domiciled in India and was incorporated on December 10, 1981 under the provisions of the Companies Act, 1956. Its registered and principal office of business is located at 16-A, Tivim Industrial Estate, Mapusa, Goa, India.

Business area of the company

The Company is engaged in the business of manufacturing and supply of semi - finished plastic lenses. It has manufacturing facilities at Tivim Industrial Estate, Mapusa - Goa.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×